rs71785313

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 2P and 8B. PM4BA1

The NM_003661.4(APOL1):​c.1164_1169delTTATAA​(p.Asn388_Tyr389del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00701 in 1,612,914 control chromosomes in the GnomAD database, including 748 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity,risk factor (no stars).

Frequency

Genomes: 𝑓 0.039 ( 410 hom., cov: 31)
Exomes 𝑓: 0.0037 ( 338 hom. )

Consequence

APOL1
NM_003661.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity; risk factor criteria provided, conflicting classifications P:4U:1B:2O:3

Conservation

PhyloP100: -0.259

Publications

225 publications found
Variant links:
Genes affected
APOL1 (HGNC:618): (apolipoprotein L1) This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
APOL1 Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 4, susceptibility to
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003661.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_003661.4.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003661.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOL1
NM_003661.4
MANE Select
c.1164_1169delTTATAAp.Asn388_Tyr389del
disruptive_inframe_deletion
Exon 6 of 6NP_003652.2
APOL1
NM_145343.3
c.1212_1217delTTATAAp.Asn404_Tyr405del
disruptive_inframe_deletion
Exon 7 of 7NP_663318.1O14791-2
APOL1
NM_001136540.2
c.1164_1169delTTATAAp.Asn388_Tyr389del
disruptive_inframe_deletion
Exon 6 of 6NP_001130012.1O14791-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOL1
ENST00000397278.8
TSL:1 MANE Select
c.1164_1169delTTATAAp.Asn388_Tyr389del
disruptive_inframe_deletion
Exon 6 of 6ENSP00000380448.4O14791-1
APOL1
ENST00000319136.8
TSL:1
c.1212_1217delTTATAAp.Asn404_Tyr405del
disruptive_inframe_deletion
Exon 7 of 7ENSP00000317674.4O14791-2
APOL1
ENST00000438034.6
TSL:4
c.1251_1256delTTATAAp.Asn417_Tyr418del
disruptive_inframe_deletion
Exon 7 of 7ENSP00000404525.2B1AH94

Frequencies

GnomAD3 genomes
AF:
0.0388
AC:
5899
AN:
152120
Hom.:
410
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.136
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.0301
GnomAD2 exomes
AF:
0.00976
AC:
2429
AN:
248746
AF XY:
0.00713
show subpopulations
Gnomad AFR exome
AF:
0.141
Gnomad AMR exome
AF:
0.00569
Gnomad ASJ exome
AF:
0.000101
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000978
Gnomad OTH exome
AF:
0.00364
GnomAD4 exome
AF:
0.00369
AC:
5397
AN:
1460676
Hom.:
338
AF XY:
0.00303
AC XY:
2204
AN XY:
726584
show subpopulations
African (AFR)
AF:
0.136
AC:
4551
AN:
33406
American (AMR)
AF:
0.00655
AC:
292
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26030
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000279
AC:
24
AN:
86064
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53340
Middle Eastern (MID)
AF:
0.00278
AC:
16
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000378
AC:
42
AN:
1111444
Other (OTH)
AF:
0.00782
AC:
472
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
234
468
702
936
1170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0388
AC:
5908
AN:
152238
Hom.:
410
Cov.:
31
AF XY:
0.0378
AC XY:
2815
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.135
AC:
5623
AN:
41506
American (AMR)
AF:
0.0137
AC:
209
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68018
Other (OTH)
AF:
0.0298
AC:
63
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
256
512
767
1023
1279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0196
Hom.:
28
Bravo
AF:
0.0451
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity; risk factor
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)
1
-
-
Focal segmental glomerulosclerosis (1)
1
-
-
Focal segmental glomerulosclerosis 4, susceptibility to (4)
1
-
-
Nephrotic range proteinuria (1)
-
-
1
not specified (1)
-
-
-
Hyalinosis, Segmental Glomerular (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.26
Mutation Taster
=196/4
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs71785313;
hg19: chr22-36662041;
COSMIC: COSV106451415;
COSMIC: COSV106451415;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.